Ashley McEvoy net worth and biography

Ashley McEvoy Biography and Net Worth

Ashley McEvoy is Executive Vice President and Worldwide Chairman, Medical Devices, Johnson & Johnson. She is a member of the Johnson & Johnson Executive Committee and leads the global Medical Devices division for the Company, generating approximately $23 billion in revenue. She has more than 25 years of experience working at Johnson & Johnson, serving in leadership roles of increasing scope and responsibility in the Consumer Health and Medical Devices sectors. Building on J&J’s rich heritage in healthcare, science and technology, Ashley leads a team that continues to display the century-plus Medical Devices pioneering spirit as they work to reimagine the future of health today. Ashley and her team act with the profound belief that the intersection of medical technology, software, and biopharmaceuticals are the key to navigating the top five causes of death worldwide and they are relentlessly pursuing that potential impact with passion.

Since assuming her current role in 2018, Ashley has strengthened the Medical Devices’ core portfolio, improved execution and commercial excellence, and refreshed the innovation agenda to elevate the standards of care and advance a market-leading pipeline of products and solutions that significantly improve the lives of patients living with cancer, myopia, osteoarthritis, heart disease and diabetes, stroke, long bone fractures, and obstetric fistula. Through this patient-centered innovator approach, Johnson & Johnson Medical Devices doubled the value of its pipeline to $10 billion in 2020 from 2018.

Under Ashley’s leadership, Johnson & Johnson Medical Devices has accelerated its ability to tackle the most pressing global healthcare challenges across four franchises in general surgery, orthopedics, eye health, and interventional solutions. Eleven platforms across these franchises generate more than $1B each in sales annually, and 80% of sales come from platforms that are #1 or #2 in the markets in which they compete. As the #2 medical devices company worldwide, Johnson & Johnson Medical Devices is propelled by their aspiration to reimagine the future of health today by innovating across the continuum of patient care, prioritizing and modernizing health, and promoting health equity and wellness. Core to the division’s strategy is delivering meaningful innovation through medical interventions that are accessible to all – and are smarter, less invasive, and more personalized at a lower cost.

Ashley is a passionate people and performance-based leader who has delivered above-market results for all four multi-billion-dollar, global companies that she has led. Her disciplined approach to portfolio optimization combines a continuous investment in the core business while progressing areas of strategic importance with high growth potential. Since Ashley entered the division, Johnson & Johnson Medical Devices has executed approximately 150 acquisitions and strategic partnerships to round out the sector’s portfolio and enhance its ability to meet patient and customer needs today— and well into the future. These investments include advancing the division’s focus on digital solutions, with acquisitions including Auris Health, Verb Surgical, and Orthotaxy.

Drawing on Johnson & Johnson’s global infrastructure, robust understanding of diseases, cross-sector expertise, vast innovation network, and trusted partnerships throughout the globe, Ashley spearheaded the company’s entrance into telehealth, robotics and digital surgery with the commercially available platforms, MONARCH® and DePuy Synthes’ VELYS™, and novel data software systems including C-SATS® and Ethicon Visible Patient. Beyond, telehealth and the amplification of robotics and analytics, Ashley and the team are igniting an attractive pipeline focused on further leveraging and democratizing digitization to support healthcare professionals worldwide by elevating their skills and judgment to reduce variability and improve outcomes across the patient’s continuum of care.

Equal to her focus on growing the business’ portfolio, Ashley is dedicated to environmental sustainability, cultivating high-performing talent, and fostering a culture of commitment to allyship, diversity, equity, and inclusion (DEI). Ashley serves as the Executive Sponsor for Johnson & Johnson’s Open&Out Employee Resource Group, a growing global network of 5,000 LGBTQIA+ professionals and allies. She is also an avid volunteer with The Trevor Project, an organization that provides crisis and suicide prevention services to youth and the LGBTQIA+ community. As an Executive Committee Board Member for AdvaMed, the leading global trade association and consortium of companies for the medical devices industry, Ashley works with medtech leaders to improve access to care and patient outcomes, and directs the industry’s response to racial disparities in health.

A Pennsylvania native, Ashley is proud to serve on the Board of Trustees for the prestigious and internationally renowned Children’s Hospital of Philadelphia, the nation's first hospital devoted exclusively to the care of children. As a Board Member, Ashley helps guide the mission of the Hospital and oversee its operations in delivering safe, high-quality, family-centered care.

Numerous leadership and philanthropic organizations have recognized Ashley’s expertise, accomplishments, and impact on the healthcare industry. She ranked #41 on Fortune’s Most Power Women List in 2019. Most recently, she was honored as one of 50 individuals recognized on Forbes’ inaugural CEO NEXT list and was ranked #1 on the Top 25 Women Leaders in Medical Devices list by The Healthcare Technology Report. She was also named a “Woman of Achievement” in 2020 by the National Association of Female Executives for her commitment and dedication to DEI.

What is Ashley McEvoy's net worth?

The estimated net worth of Ashley McEvoy is at least $3.57 million as of July 28th, 2020. Ms. McEvoy owns 21,682 shares of Johnson & Johnson stock worth more than $3,571,025 as of September 29th. This net worth approximation does not reflect any other investments that Ms. McEvoy may own. Learn More about Ashley McEvoy's net worth.

How do I contact Ashley McEvoy?

The corporate mailing address for Ms. McEvoy and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400. Learn More on Ashley McEvoy's contact information.

Has Ashley McEvoy been buying or selling shares of Johnson & Johnson?

Ashley McEvoy has not been actively trading shares of Johnson & Johnson within the last three months. Most recently, Ashley Mcevoy sold 29,000 shares of the business's stock in a transaction on Tuesday, July 28th. The shares were sold at an average price of $147.47, for a transaction totalling $4,276,630.00. Following the completion of the sale, the executive vice president now directly owns 21,682 shares of the company's stock, valued at $3,197,444.54. Learn More on Ashley McEvoy's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Director ), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Michael Sneed (COO), Paulus Stoffels (VP), Kathryn Wengel (EVP), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, insiders at the sold shares 5 times. They sold a total of 106,842 shares worth more than $18,885,128.67. The most recent insider tranaction occured on June, 10th when EVP Kathryn E Wengel sold 40,000 shares worth more than $6,920,000.00. Insiders at Johnson & Johnson own 0.4 % of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 6/10/2022.

Ashley McEvoy Insider Trading History at Johnson & Johnson

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/28/2020Sell29,000$147.47$4,276,630.0021,682View SEC Filing Icon  
See Full Table

Ashley McEvoy Buying and Selling Activity at Johnson & Johnson

This chart shows Ashley Mcevoy's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Read More

Today's Range

Now: $164.70
Low: $163.89
High: $167.16

50 Day Range

MA: $167.44
Low: $161.33
High: $174.59

2 Week Range

Now: $164.70
Low: $155.72
High: $186.69


535,142 shs

Average Volume

7,618,863 shs

Market Capitalization

$433.03 billion

P/E Ratio


Dividend Yield